ELLIPSES PHARMA LTD

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameELLIPSES PHARMA LTD
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 09542015
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of ELLIPSES PHARMA LTD?

    • Other professional, scientific and technical activities n.e.c. (74909) / Professional, scientific and technical activities

    Where is ELLIPSES PHARMA LTD located?

    Registered Office Address
    10 Stratton Street
    W1J 8LG London
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for ELLIPSES PHARMA LTD?

    OverdueYes
    Next Accounts
    Next Accounts Period End OnMar 31, 2024
    Next Accounts Due OnMar 31, 2025
    Last Accounts
    Last Accounts Made Up ToMar 31, 2023

    What is the status of the latest confirmation statement for ELLIPSES PHARMA LTD?

    Last Confirmation Statement Made Up ToMar 07, 2026
    Next Confirmation Statement DueMar 21, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMar 07, 2025
    OverdueNo

    What are the latest filings for ELLIPSES PHARMA LTD?

    Filings
    DateDescriptionDocumentType

    Director's details changed for Bissan Musa on Apr 04, 2025

    2 pagesCH01

    Appointment of Bissan Musa as a director on Mar 25, 2025

    2 pagesAP01

    Termination of appointment of Waleed Al Mokarrab Al Muhairi as a director on Mar 25, 2025

    1 pagesTM01

    Termination of appointment of Maha Taysir Barakat as a director on Mar 25, 2025

    1 pagesTM01

    Confirmation statement made on Mar 07, 2025 with updates

    10 pagesCS01

    Termination of appointment of David Cook as a secretary on Feb 28, 2025

    1 pagesTM02

    Appointment of Sarah Jackson as a secretary on Feb 28, 2025

    2 pagesAP03

    Statement of capital following an allotment of shares on Feb 07, 2025

    • Capital: GBP 124,383.247
    3 pagesSH01

    Statement of capital following an allotment of shares on Jan 20, 2025

    • Capital: GBP 123,938.802
    3 pagesSH01

    Statement of capital following an allotment of shares on Oct 23, 2024

    • Capital: GBP 122,438.802
    3 pagesSH01

    Termination of appointment of Rajan Vipin Jethwa as a director on Aug 22, 2024

    1 pagesTM01

    Statement of capital following an allotment of shares on Jun 28, 2024

    • Capital: GBP 122,313.516
    3 pagesSH01

    Statement of capital following an allotment of shares on Jun 28, 2024

    • Capital: GBP 122,438.516
    3 pagesSH01

    Statement of capital following an allotment of shares on Mar 26, 2024

    • Capital: GBP 122,251.016
    3 pagesSH01

    Confirmation statement made on Mar 07, 2024 with updates

    9 pagesCS01

    Statement of capital following an allotment of shares on Dec 30, 2023

    • Capital: GBP 121,751.016
    3 pagesSH01

    Statement of capital following an allotment of shares on Dec 30, 2023

    • Capital: GBP 120,126.016
    3 pagesSH01

    Statement of capital following an allotment of shares on Nov 15, 2023

    • Capital: GBP 119,876.016
    3 pagesSH01

    Group of companies' accounts made up to Mar 31, 2023

    39 pagesAA

    Statement of capital following an allotment of shares on Jun 12, 2023

    • Capital: GBP 119,806.016
    3 pagesSH01

    Statement of capital following an allotment of shares on May 24, 2023

    • Capital: GBP 119,306.02
    3 pagesSH01

    Appointment of David Cook as a secretary on Mar 31, 2023

    2 pagesAP03

    Termination of appointment of Jonathan Maxmin as a secretary on Mar 31, 2023

    1 pagesTM02

    Confirmation statement made on Mar 07, 2023 with updates

    7 pagesCS01

    Statement of capital following an allotment of shares on Mar 07, 2023

    • Capital: GBP 117,091.73
    3 pagesSH01

    Who are the officers of ELLIPSES PHARMA LTD?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    JACKSON, Sarah
    Stratton Street
    W1J 8LG London
    10
    England
    Secretary
    Stratton Street
    W1J 8LG London
    10
    England
    333337820001
    COOK, David
    Stratton Street
    W1J 8LG London
    10
    England
    Director
    Stratton Street
    W1J 8LG London
    10
    England
    United KingdomBritishDirector224874420002
    EVANS, Christopher Thomas, Professor
    Stratton Street
    W1J 8LG London
    10
    England
    Director
    Stratton Street
    W1J 8LG London
    10
    England
    United KingdomBritishDirector159856400001
    KHATER, Fahad Salah
    Stratton Street
    W1J 8LG London
    10
    England
    Director
    Stratton Street
    W1J 8LG London
    10
    England
    EnglandBritishDirector240058090002
    MUSA, Bissan
    Muroor Road
    Abu Dhabi
    Al Mamoura A Building
    United Arab Emirates
    Director
    Muroor Road
    Abu Dhabi
    Al Mamoura A Building
    United Arab Emirates
    United Arab EmiratesCanadianRisk Management334288470001
    COOK, David
    Stratton Street
    W1J 8LG London
    10
    England
    Secretary
    Stratton Street
    W1J 8LG London
    10
    England
    307491220001
    MAXMIN, Jonathan
    Stratton Street
    W1J 8LG London
    10
    England
    Secretary
    Stratton Street
    W1J 8LG London
    10
    England
    223296690001
    AL MUHAIRI, Waleed Al Mokarrab
    Muroor Road
    Al Mamoura A Building
    Abu Dhabi
    United Arab Emirates
    Director
    Muroor Road
    Al Mamoura A Building
    Abu Dhabi
    United Arab Emirates
    United Arab EmiratesEmiratiCompany Director255649160001
    BARAKAT, Maha Taysir, Dr
    A Building
    Muroor Road
    A1 Mamoura
    Abu Dhabi
    United Arab Emirates
    Director
    A Building
    Muroor Road
    A1 Mamoura
    Abu Dhabi
    United Arab Emirates
    United Arab EmiratesEmiratiCompany Director256040360001
    JETHWA, Rajan Vipin, Dr
    Stratton Street
    W1J 8LG London
    10
    England
    Director
    Stratton Street
    W1J 8LG London
    10
    England
    EnglandBritishCompany Director197311790001
    MCVIE, Gordon
    Stratton Street
    W1J 8LG London
    10
    England
    Director
    Stratton Street
    W1J 8LG London
    10
    England
    United KingdomBritishNone199255730002
    ZAHOOR, Shafia
    c/o Excalibur
    Berkeley Square
    W1J 6BD London
    Berkeley Square House
    United Kingdom
    Director
    c/o Excalibur
    Berkeley Square
    W1J 6BD London
    Berkeley Square House
    United Kingdom
    EnglandBritishAccountant162442700001

    Who are the persons with significant control of ELLIPSES PHARMA LTD?

    Persons with significant controls
    NameNotified OnAddressCeased
    Mr Ali Ahmed Abd Al Mouhsen Alfrayhat
    Muroor Road
    Al Mamoura A Building
    Abu Dhabi
    United Arab Emirates
    Dec 19, 2018
    Muroor Road
    Al Mamoura A Building
    Abu Dhabi
    United Arab Emirates
    No
    Nationality: Jordanian
    Country of Residence: United Arab Emirates
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Ectoplasm Limited
    Sixty Circular Road
    IM1 1AE
    Douglas
    1st Floor
    Isle Of Man
    United Kingdom
    Jan 04, 2017
    Sixty Circular Road
    IM1 1AE
    Douglas
    1st Floor
    Isle Of Man
    United Kingdom
    Yes
    Legal FormCompany
    Country RegisteredIsle Of Man
    Legal AuthorityEnglish Law Isle Of Man
    Place RegisteredIsle Of Man
    Registration Number013201v
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Mr Christopher Chipperton
    Davidson & Co
    Suite 504,Shangri La Offices, Sheikh Zayed Road
    PO BOX 340
    Dubai
    Davidson & Co
    United Arab Emirates
    Apr 06, 2016
    Davidson & Co
    Suite 504,Shangri La Offices, Sheikh Zayed Road
    PO BOX 340
    Dubai
    Davidson & Co
    United Arab Emirates
    Yes
    Nationality: British
    Country of Residence: Dubai, United Arab Emirates
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Christopher Thomas Evans
    Berkley Square
    W1J 6BD London
    Berkeley Square House
    England
    Apr 06, 2016
    Berkley Square
    W1J 6BD London
    Berkeley Square House
    England
    Yes
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0